SHANGHAI, China, April 30, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, today announced that the China National Medical Products Administration (NMPA) has accepted a …Read More
Led by UCSF Quantitative Biosciences Institute Director, Nevan Krogan, PhD, international effort including researchers from UCSF, Gladstone Institutes, Icahn School of Medicine at Mount Sinai and Institut Pasteur unveils promising compounds for clinical testing
SAN FRANCISCO, Calif., April 30, 2020 …Read More
ลอสแองเจลิส, April 30, 2020 (GLOBE NEWSWIRE) — ผ่าน NetworkWire — InvestorBrandNetwork (“IBN”
VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received …Read More
MONTREAL, April 29, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the first quarter ended March 31, 2020 on Thursday, May 7, 2020.
On May 7 at 8:00 a.m., EDT, Éric Martel, President and Chief …Read More